Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha.
about
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapyProtection against lipopolysaccharide-induced death by fluoroquinolones.Immunomodulating activity of quinolones: review.Premature Therapeutic Antimicrobial Treatments Can Compromise the Diagnosis of Late Periprosthetic Joint Infection.Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.Modulatory effect of antibiotics on cytokine production by human monocytes in vitro.Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro.Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.Enrofloxacin in therapeutic doses alters cytokine production by porcine PBMCs induced by lipopolysaccharide.
P2860
Q28571264-0E40EFFE-9D95-4660-A96F-E19DF3ECAA8DQ33594884-4773333D-031E-4741-81A9-4FDA08D381E4Q34562603-438E596E-762F-41ED-8E90-2F17A718835FQ35689361-CAE70719-5AE5-4DB9-822C-3DEB1A63B02AQ38904168-8924367D-5C29-43CB-BCF2-D227260970D6Q39782217-3FFE5333-78FB-4429-A3C2-0021E72506FEQ39785340-AB247D9E-935B-40F5-A584-52AAD12C6742Q44569280-0001D3A2-B724-43F6-BDA5-018A312B5169Q51169060-269D43C0-4162-4E60-87CE-86616B20BB9D
P2860
Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@en
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@nl
type
label
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@en
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@nl
prefLabel
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@en
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@nl
P2093
P1476
Ciprofloxacin treatment in viv ...... tumour necrosis factor-alpha.
@en
P2093
Gougerot-Pocidalo MA
P2860
P304
P356
10.1111/J.1365-2249.1991.TB05728.X
P577
1991-08-01T00:00:00Z